Anisodamine clinical trials
How each study uses anisodamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the anisodamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- anisodamine
- 1
Studies by the year they started
3 studies that test it; most in 2015 (1)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
Jinhua Central Hospital (1) · First Affiliated Hospital of Wannan Medical College (1) · Chen Ying (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses anisodamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Effects of Anisodamine on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic ShockNot yet recruitingNot applicableFirst Affiliated Hospital of Wannan Medical CollegeNCT07657702Written as Anisodamine intravenous infusion
- Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With SepsisRecruitingNot applicableChen YingNCT05634057Written as Anisodamine hydrobromide combined with heparin
- Anisodamine Critically Ill SeptIc ShockCompletedPhase 1/2Jinhua Central HospitalNCT02442440Written as anisodamine
Given beside what is tested · 1 — anisodamine is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with anisodamine
- Effect of Glycopyrrolate on Nausea and Vomiting After ERCP OperationCompletedPhase 1/2Jie ChenNCT06045364Written as Anisodamine
- Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal PainCompletedPhase 3Boehringer IngelheimNCT01929044Written as 654-II (anisodamine)
Codes
What other systems call anisodamine · ClinicalTrials.gg INT002282
- MeSH (NLM) C003922anisodamineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 01343Q8EL8ANISODAMINEConfirmed FDA, NLM
- NCI Thesaurus C221848AnisodamineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C003922 | anisodamine | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 01343Q8EL8 | ANISODAMINE | Confirmed FDA, NLM |
| NCI Thesaurus | C221848 | Anisodamine | One source FDA |
Also registered as 6-hydroxyhyoscyamine (UNII QQZ59S1DUT) and anisodamine hydrobromide (UNII 4RKP5CSA1O).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.